These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 28844373)

  • 1. Blood derived eye drops for the treatment of cornea and ocular surface diseases.
    Giannaccare G; Versura P; Buzzi M; Primavera L; Pellegrini M; Campos EC
    Transfus Apher Sci; 2017 Aug; 56(4):595-604. PubMed ID: 28844373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Blood-Derived Eye Drops for the Treatment of Corneal Neuropathic Pain.
    Anam A; Liu C; Tong L; Liu YC
    J Ocul Pharmacol Ther; 2024 Jun; 40(5):281-292. PubMed ID: 38648544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Blood-derived topical therapy for ocular surface diseases.
    Soni NG; Jeng BH
    Br J Ophthalmol; 2016 Jan; 100(1):22-7. PubMed ID: 26178904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma rich in growth factors (PRGF) eye drops stimulates scarless regeneration compared to autologous serum in the ocular surface stromal fibroblasts.
    Anitua E; de la Fuente M; Muruzabal F; Riestra A; Merayo-Lloves J; Orive G
    Exp Eye Res; 2015 Jun; 135():118-26. PubMed ID: 25708868
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of heat-treatment on plasma rich in growth factors-derived autologous eye drop.
    Anitua E; Muruzabal F; De la Fuente M; Merayo-Lloves J; Orive G
    Exp Eye Res; 2014 Feb; 119():27-34. PubMed ID: 24345372
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autologous serum for ocular surface diseases.
    Quinto GG; Campos M; Behrens A
    Arq Bras Oftalmol; 2008; 71(6 Suppl):47-54. PubMed ID: 19274411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Autologous serum-eye-drops for ocular surface disorders. A literature review and recommendations for their application].
    Geerling G; Hartwig D
    Ophthalmologe; 2002 Dec; 99(12):949-59. PubMed ID: 12478384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autologous serum eye drops for the treatment of ocular surface disease.
    Azari AA; Rapuano CJ
    Eye Contact Lens; 2015 May; 41(3):133-40. PubMed ID: 25603439
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blood-Based Treatments for Severe Dry Eye Disease: The Need of a Consensus.
    Bernabei F; Roda M; Buzzi M; Pellegrini M; Giannaccare G; Versura P
    J Clin Med; 2019 Sep; 8(9):. PubMed ID: 31533289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biological Stability of Plasma Rich in Growth Factors Eye Drops After Storage of 3 Months.
    Anitua E; Muruzabal F; Pino A; Merayo-Lloves J; Orive G
    Cornea; 2013 Oct; 32(10):1380-6. PubMed ID: 23974892
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ready-made allogeneic ABO-specific serum eye drops: production from regular male blood donors, clinical routine, safety and efficacy.
    Harritshøj LH; Nielsen C; Ullum H; Hansen MB; Julian HO
    Acta Ophthalmol; 2014 Dec; 92(8):783-6. PubMed ID: 24629028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Autologous serum and alternative blood products for the treatment of ocular surface disorders].
    Geerling G; Unterlauft JD; Kasper K; Schrader S; Opitz A; Hartwig D
    Ophthalmologe; 2008 Jul; 105(7):623-31. PubMed ID: 18607606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteomic Characterization of Plasma Rich in Growth Factors and Undiluted Autologous Serum.
    Anitua E; Muruzabal F; Pino A; Prado R; Azkargorta M; Elortza F; Merayo-Lloves J
    Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quality standards, safety and efficacy of blood-derived serum eye drops: A review.
    van der Meer PF; Seghatchian J; Marks DC
    Transfus Apher Sci; 2016 Feb; 54(1):164-7. PubMed ID: 26847866
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial Effects of Plasma Rich in Growth Factors (PRGF) Versus Autologous Serum and Topical Insulin in Ocular Surface Cells.
    Anitua E; de la Fuente M; Sánchez-Ávila RM; de la Sen-Corcuera B; Merayo-Lloves J; Muruzábal F
    Curr Eye Res; 2023 May; 48(5):456-464. PubMed ID: 36695530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autologous serum eye drops for ocular surface disorders.
    Geerling G; Maclennan S; Hartwig D
    Br J Ophthalmol; 2004 Nov; 88(11):1467-74. PubMed ID: 15489495
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autologous serum eye drops for ocular surface disorders.
    Cui D; Li G; Akpek EK
    Curr Opin Allergy Clin Immunol; 2021 Oct; 21(5):493-499. PubMed ID: 34261888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autologous serum eye drops for the treatment of dry eye diseases.
    Kojima T; Higuchi A; Goto E; Matsumoto Y; Dogru M; Tsubota K
    Cornea; 2008 Sep; 27 Suppl 1():S25-30. PubMed ID: 18813071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of Acellular Umbilical Cord-Derived Tissues in Corneal and Ocular Surface Diseases.
    Tovar AA; White IA; Sabater AL
    Medicines (Basel); 2021 Feb; 8(2):. PubMed ID: 33572327
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implementation of a standardised method for the production of allogeneic serum eye drops from regular blood donors in a Norwegian University Hospital: Some methodological aspects and clinical considerations.
    Espinosa A; Hjorth-Hansen H; Aasly K; Teigum I; Sivertsen G; Seghatchian J
    Transfus Apher Sci; 2015 Aug; 53(1):88-91. PubMed ID: 26027793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.